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Abstract
Background: The new Certas™ shunt for the treatment of hydrocephalus has seven standard pressure settings that
according to the manufacturer range from 36 to 238 mmH2O, and an additional “Virtual Off” setting with an
opening pressure >400 mmH2O. Information on actual pressure response and reliability of shunt performance is
important in clinical application, especially the “Virtual Off” setting as a non-surgical replacement for shunt ligation.
The objective of this study was to evaluate the in-vitro hydrodynamic performance of the Certas™ shunt.
Methods: Six new Certas™ shunts with proximal and distal catheters were tested with an automated, computerized
test system that raised the pressure from zero to a maximum pressure and back to zero at each valve setting.
Opening pressure and flow resistance were determined.
Results: For settings 1–7 the measured opening pressure range was 26 to 247 mmH2O, and the mean change in
opening pressure for a one-step adjustment was between 33 and 38 mmH2O. For setting 8 (“Virtual Off”) the
measured mean opening pressure was 494±34 mmH2O (range 451 to 556 mmH2O). The mean outflow resistance
was 7.0 mmHg/ml/min (outflow conductance 17.9 μl/s/kPa).
Conclusions: The six shunts had similar characteristics and closely matched the manufacturer’s specifications for
opening pressure at settings 1–7. The opening pressure for the “Virtual Off” setting was nearly 500 mmH2O, which is
100 mmH2O higher than the manufacturer’s specification of “>400” and should be functionally off for most patients
with communicating hydrocephalus. Clinical studies are needed to evaluate if the CSF dynamic profile persists after
implantation in patients.
Keywords: Hydrocephalus, Normal pressure hydrocephalus, CSF, Cerebrospinal fluid, Shunt, Intracranial pressure,
Outflow resistance, Conductance
Introduction
Improvements in the modern shunt for drainage of cere-
brospinal fluid (CSF) in the surgical treatment of hydro-
cephalus have aimed to include features in shunt design
that reduce complications and improve clinical outcome.
One goal has been to increase control over the amount of
CSF drainage, such as adjustable shunt valves that permit
postoperative adjustment of the shunt valve opening pres-
sure. Several different brands of adjustable CSF shunts are
available, characterized by opening pressures ranging from
approximately 0 to 200 mm H2O, depending on the brand
and the model. If a patient’s clinical response after shunt
surgery is inadequate, lowering the shunt valve opening
pressure may improve outcome while avoiding surgery to
remove and replace the shunt valve. Alternately, in
patients with over-drainage symptoms of headache or
hearing change, or signs such as subacute or chronic sub-
dural effusion or hemorrhage, treatment can be initiated
by increasing the shunt valve opening pressure, thus
avoiding surgery [1]. In several clinical settings, such as
subacute or chronic subdural fluid collections, or efforts to
achieve shunt independence, the clinician may prefer to
stop CSF drainage. There is currently no valve system that
provides this option, and even adjustable valves must be
disabled by surgical ligation of the system because flow
through the shunt is still possible at a valve opening pres-
sure of 200 mmH2O.
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Certas™ is an adjustable shunt with 7 pressure settings that
range, according to the manufacturer, from 36 to 238 mm
H2O. An interesting feature of the shunt is an eighth setting
with a very high opening pressure (>400 mm H2O), that is
described as “Virtual Off”. The aim of our study was to
evaluate the hydrodynamic characteristics of the Certas™
programmable valve with an in-vitro bench test system.
Methods
The CSF shunts
Six new Certas™ shunts without a SiphonGuard™ were
purchased from Codman (Wokingham, UK). The shunts
were tested with the original 14 cm proximal and 120 cm
distal catheters. The proximal (ventricular) catheter was
shortened approximately two centimeter in order to re-
move the perforated part so that it could be attached to
the test rig for perfusion.
The test system
The fully automated test system (Figure 1) used by the
Umeå hydrocephalus group (www.hydrocephalus.se) has
been described previously [2-4]. The system was updated
with a new computer (Lifebook E780, Fujitsu, Tokyo, Japan)
and a new data acquisition card (NI DAQCard-6036E,
National Instruments, Austin TX,US). The software for the
test system and analysis was developed in LabVIEW
(National Instruments, Austin, TX, US). The computerized
system collects data and regulates the pressure according to
a pre-set pressure pattern. The inlet pressure to the shunt
was regulated by air pressurizing a sealed 5 L bottle partially
filled with water while measuring the proximal pressure of
the CSF shunt with differential pressure transducers
(LPM8000, Druck, Leicester, England). To prevent air
bubbles, the de-ionized water in the test rig was first de-
aerated by boiling for 10 min under vacuum. All tubing was
visually inspected and any air bubbles were purged before
the protocol start of each new shunt setting. Flow was cal-
culated utilizing the principle of a differential pressure flow
meter. Using an identical pressure transducer, the pressure
drop across a glass constriction with a calibrated resistance
was continuously measured. The flow rate is directly pro-
portional to the pressure drop (Figure 1).
To simulate the effect of subcutaneous tissue pressure
on the valve mechanism [5], the shunt was submerged in
water at a depth of 100 mm. The distal catheter was led
to an overflow container with a water level held constant
at the zero pressure level to ensure a stable hydrostatic
reference pressure. Because fluid viscosity and valve op-
erating characteristics are temperature dependent, the
test system was built into an incubator set at 37°C
(Figure 1).
Figure 1 The test system. Proximal pressure of the shunt was controlled by air pressurizing the sealed bottle with the computer controlled air
pump. Flow through the shunt was estimated from the pressure drop over the glass constriction using the calibrated resistance. Both the
pressure drop over the constriction and the proximal shunt pressure were measured with differential pressure transducers from Druck (LPM8000).
Outflow from the shunt was led into an overflow container with a constant water level at the zero pressure level. The set-up was placed in an
incubator set at 37°C. Computer–controlled solenoid cocks were used to automatically perform the protocol, including pressure recalibrations.
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Solenoid valves were computer controlled and the sys-
tem performed all steps of the pre-programmed test
protocol automatically, including a two-point pressure
recalibration at zero and 305 mm H2O before testing
at each valve opening pressure setting. For each valve
setting, the inlet pressure was gradually increased
from zero to a maximum pressure and then back to
zero according to a triangular shaped waveform with
a cycle period of 60 min [4]. The triangular wave was
repeated 6 times at each setting for each valve for a
total of 288 cycles. If air bubbles were detected during
a cycle, the cycle was omitted (304 cycles with 16
omissions were necessary to achieve 288 cycles). Every
shunt was tested at all eight opening pressure
settings.
Typical flow versus pressure curves can be seen in
Figure 2. The figure also shows hysteresis of the pres-
sure-flow curve at each setting. A higher pressure is
required to open the valve and sustain flow during the
rising phase of the inlet pressure, but during the
decreasing phase of the inlet pressure, the flow is sus-
tained at a lower pressure so that the closing pressure of
the valve is slightly lower than the opening pressure. To
ensure that the flow rate reached at least 0.9 ml/min,
used in the calculation for flow resistance and opening
pressure (see Statistics and Figure 2), independent of
shunt setting, while at the same time avoiding very high
flow rates at low pressure settings, a maximum pressure
was manually determined for each setting before starting
the automatic protocol. In the figure it can be seen how
different settings required different maximum pressures.
Statistics
Opening conductance (1/Rout) was determined as the
slope of a linear regression between 0.45 and 0.9 ml/min
(Figure 2). The shunt valve opening pressure was consid-
ered to be the pressure value at the intersection of the
regression line with the x-axis (i.e., zero flow). Results at
each shunt setting are presented as the mean value of 6
cycles per shunt for all 6 shunts.
To test for differences between groups analysis of vari-
ance (ANOVA) with Bonferroni Post Hoc test were used.
p<0.05 was considered statistically significant.
Results
The shunt valve opening pressures were significantly dif-
ferent for settings 1 – 7( p<0.001, n=42, ANOVA) and
post hoc analysis showed that all settings were significantly
different from each other. The mean change in opening
pressure for a one-step adjustment was between 33 and
38 mm H2O for settings 1 to 7 (Figure 3). The measured
opening pressure at the lowest setting (setting 1, 36 mm
H2O) was 26 mm H2O and the measured opening pres-
sure at the highest (setting 7, 238 mm H2O) was 247 mm
H2O. For setting 8 (“Virtual Off”, >400 mm H2O), the
measured mean opening pressure for the six shunts was
494±34 mm H2O( r a n g e4 5 1t o5 5 6m mH 2O) and sig-
nificantly higher than setting 7 (n=12, p<0.001). Because
the 60 min cycle for the triangular pressure waveform pro-
duces the shunt’s undisturbed pressure-flow characteris-
tics, the opening pressure determined by this test for each
setting should be interpreted as a maximum operating
pressure for that setting.
Figure 2 Typical pressure-flow curves for settings 1 – 8 in order from left to right. For each shunt setting, the valve opening pressure is
determined during the rising phase of the inlet pressure. When the pressure enters the decreasing phase of the inlet pressure, the flow reduces,
but with some hysteresis so that the closing pressure of the valve is lower than the opening pressure. The hysteresis was more pronounced for
setting 8. The calculation for estimation of Rout and opening pressure is exemplified by the dotted line fitted against the opening phase of data
from setting 3. The slope of the curve gives 1/Rout and the intersection of the line with the pressure axis is the opening pressure.
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through the system) was dependent on the shunt setting
(p<0.01, n=48, Figure 4). Post hoc analysis showed that
settings 1 and 2 differed from settings 6 and 7, although
the differences were small, varying from 6.7 mmHg/ml/
min for setting 1 to 7.3 mmHg/ml/min for setting 7. The
mean shunt outflow resistance was 7.0±0.2 mmHg/ml/min
(mean±SD), corresponding to an outflow conductance of
17.9±0.5 μl/s/kPa .
Discussion
This in vitro test of the Certas™ valve has demonstrated a
reliable, consistent step-wise regulation of opening pres-
sure with an acceptable outflow resistance for all shunt
valve settings. The six tested shunts had similar character-
istics and were well within the manufacturer’s specifica-
tions for opening pressure at settings 1–7, with no overlap
between settings (Figure 3). For settings 1-7, the opening
pressure ranged from 26 to 247 mm H2O. The increment
between settings was 33–38 mm H2O( 2.7 mm Hg),
which is larger than the 10 mm H2O (0.7 mm Hg) incre-
ment for the Codman Hakim shunt [4] and more similar
to increments for the Medtronic Strata shunt [2]. For set-
ting 8, “Virtual Off”, we determined the opening pressure
was nearly 500 mm H2O, which is 100 mm H2Oh i g h e r
than the minimum of 400 mm H2O specified by the
manufacturer. With the shunt implanted in patients, the
cardiac related pulsations of intracranial pressure (ICP), in
combination with the hysteresis characteristics of the valve
(Figure 2) will probably result in the shunt operating
within the boundaries of the hysteresis curve at each set-
ting. Thus, the opening pressure of the shunt in a patient
can be expected to be 10-25 mm H2O lower than the
opening pressure determined by the test system.
In principle, the shunt’s main function is to create a CSF
outflow pathway parallel to the patient’s CSF pathways,
which are impaired and have increased CSF outflow resist-
ance that plays a role in the pathophysiology of hydro-
cephalus. To anticipate an individual patient’sC S F
dynamics after shunt surgery, it is essential to know the
shunt operating characteristics and the patient’s preopera-
tive CSF dynamics, which can be determined with an infu-
sion test [3,7]. Rout >18 mmHg/ml/min is considered
indicative of a response to shunting in patients with idio-
pathic normal pressure hydrocephalus (iNPH) [8]. The
most important parameters for the shunt are the outflow
resistance when the shunt is open, and the opening pres-
sure of the valve at each setting.
Figure 3 Measured value of shunt opening pressure for the 8 settings (solid black squares) and the manufacturer’s specifications for
each shunt setting (open black circles) plotted against the manufacturer’s specification for opening pressure. Error bars show the 95%
confidence level based on the six shunts. Tolerance limits for each shunt setting per manufacturer’s specifications are shown as solid lines for
comparison. For the highest setting, only the lower limit of opening pressure>400 mm H2O is specified by the manufacturer; thus, no upper
tolerance limit is shown.
Eklund et al. Fluids and Barriers of the CNS 2012, 9:12 Page 4 of 7
http://www.fluidsbarrierscns.com/content/9/1/12The shunt outflow resistance describes the relationship
between pressure and flow when the valve is open. The
mean Rout is 7.0 mmHg/ml/min for the Certas™,a n dt h e
variation between settings (6.7 to 7.3 mmHg/ml/min), while
statistically significant, is small enough from a clinical per-
spective to be regarded as independent of the valve setting.
In the test system, the mean Rout comprises the sum of Rout
from the proximal catheter, the valve mechanism, and the
distal catheter. From specifications provided in the shunt
package insert, we can calculate that (1) the shunt valve Rout
should be approximately 1.3 mmHg/ml/min, (2) the distal
catheter Rout should be approximately 5.0 mmHg/ml/min,
and if the proximal catheter resistance was approximately
0.7 mmHg/ml/min, the combined value is equal to the
7.0 mmHg/ml/min measured in this study. This is slightly
higher than most shunts on the market [2-4].
The shunt outflow resistance of the Certas™
programmable valve (7.0 mmHg/ml/min) is lower than
the physiological mean outflow resistance reported for
patients with NPH (17.6 mmHg/ml/min) [9] and just
below the median Rout (8.6 mmHg/ml/min) reported for
healthy elderly [6]. Therefore, in a patient with a shunt,
the shunt will usually be the path of least resistance for
CSF outflow, and it will dominate the CSF pathways, cre-
ating a low resistance CSF dynamic system whenever the
valve is open. As a result, measurement of CSF outflow
resistance can be used to determine if a shunt is func-
tioning or obstructed. The Rout of a patient with an
obstructed shunt is high, and usually similar to the
patient’s pre-shunt Rout [10,11]. In Europe, when patients
are evaluated for suspected hydrocephalus, infusion test-
ing is often used to characterize the CSF dynamic system
to determine whether Rout is abnormal [12] and shunt
malfunction is present [10,13]. The expected Rout in a
patient with a functioning Certas shunt should be in the
range of 4.0 to 6.5 mmHg/ml/min (conductance 20 to 31
μl/s/kPa).
The opening pressure is the differential pressure across
the valve mechanism needed for the valve mechanism to
open. For example, with a ventriculo-peritoneal shunt con-
figuration, for the valve to open when the patient is hori-
zontal, the difference between the CSF pressure and the
downstream pressure, which is the intra-abdominal pres-
sure, must be greater than the valve opening pressure.
Recent reports support the use of a high valve setting
on adjustable shunts as a noninvasive method to treat
subacute or chronic subdural fluid collections or hema-
tomas that have resulted from over drainage [14]. The
opening pressure of settings 6 and 7 of the Certas™ valve
are both higher than the opening pressure of the highest
setting of the Codman Hakim [4] and Strata shunts [2].
We confirmed that the Certas™ valve setting 8, “Virtual
Off”, has an opening pressure range of 451 to 556 mm
H2O, which is significantly higher than the highest shunt
setting of other adjustable valves, and can probably for
most patients be regarded as functionally closed. Other
potential uses for such high shunt settings include grad-
ually raising the shunt setting in an attempt to make a
patient shunt independent, or using the system as a
“back up” after endoscopic third ventriculostomy (ETV),
where the shunt would open at a very high CSF pressure
that would occur if the ETV were to fail. The availability
of higher opening pressures may also obviate the need
for subsequent surgical implantation of an additional re-
sistance device (anti-siphon device) in some patients.
The proSA
® shunt from Miethke has a comparable solu-
tion to the high pressure setting with an adjustable anti-
gravitational device which can be adjusted to a counter
Figure 4 Shunt outflow resistance for six shunts at each of the 8 shunt settings (shown in the labels). Error bars show the 95% confidence
limits. The shaded area shows the reference range (10
th to 90
th percentile) of Rout for healthy elderly [6].
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Certas™, the proSA
® is only active in the upright position
and in the supine position the opening pressure of that de-
vice is zero. Shunt system flow is then dependent on the
opening pressure of the standard differential valve placed
in series with the proSA
®. Although not evaluated in this
study, the Certas™ shunt system is available with the
SiphonGuard™ anti-siphon device. In a previous study [4]
we found that in the supine position neither the opening
pressure nor the resistance was changed in the Codman
Hakim valve system by adding the SiphonGuard™,n o r
were they affected by positioning the SiphonGuard™ either
10 cm above or 20 cm below the ventricular catheter tip.
We expect that the same will hold for the Certas™ because
the basic differential-pressure shunt design is the same.
An important question is whether the “Virtual Off” set-
ting is likely to be functionally off in a patient. Portnoy
et al. suggested that the perfusion pressure (PP) through
the shunt is equal to: ICP+hydrostatic pressure – intra
abdominal pressure – shunt opening pressure [15]. The
PP must be greater than zero for the valve to open and
CSF to flow. In the supine position the hydrostatic pres-
sure is zero. Abdominal pressure is normally in the range
of 70 to 190 mm H2O, and is dependent on obesity [16].
ICP in healthy elderly is 100 to 196 mm H2O [6] and in
iNPH patients it is lower than 240 mm H2O [17]. In
overnight monitoring, ICP is shown to be slightly higher
during sleep, but periods of ICP above 205 mm H2O are
rare in communicating hydrocephalus [18]. Plateau
waves with large ICP increases could cause shunt flow,
but they are not a typical feature in NPH patients [20].
Thus, in the supine position, using the limits of normal
values for each variable and an opening pressure of 400,
we can calculate that PP=(240+0 – 70 - 400)=−230
and no CSF will flow through the Certas™ shunt.
In the sitting position ICP is approximately zero [18-20].
Abdominal pressure on average increases with 120 mm
H2O in the 45° sitting position [16] and in NPH patients
the abdominal pressure in the sitting position is between
150 mm H2O[ 2 0 ]a n d2 4 0m mH 2O [19]. The hydrostatic
pressure will of course depend on the subject, but can be
a s s u m e da r o u n d5 0 0t o6 0 0m mH 2O. The worst case sce-
nario for upright PP=(0+600 – 150 - 400)=50, which
means that the Certas™ shunt valve could open. This shows
that this limit is tight and that there is still risk for shunt
f l o w .H o w e v e r ,e x t r a p o l a ting the data from Miyake et al.
[19], who measured ICP and abdominal pressure with dif-
ferent shunt settings up 200 mm H2O, to a shunt opening
pressure of 400 mm H2O, indicates that the flow would be
zero in all but one of their patients. Considering that the
Certas™ shunt in this study had a mean shunt opening pres-
sure above the limit of 400 mm H2O for all shunts and that
in individual subjects the body probably “self compensates”
for a larger hydrostatic pressure gradient with a larger
increase in abdominal pressure for a taller person, we be-
lieve that the “Virtual Off” setting in patients with iNPH
should act essentially as an off setting for most patients.
However, we emphasize that this needs to be verified in the
clinical setting.
The “Virtual Off” setting has applicability for research
protocols. This setting could be used to non-invasively turn
on or off the shunt in a blinded protocol, which previously
has required either surgical clipping of the shunt catheter at
the time of implantation [21] or implantation of a “dummy”
shunt with an internal occlusion [22]. Reversal of the
placebo condition in these studies required an additional
surgical procedure, which is a significant risk from the per-
spective of research ethics, and may be a barrier to recruit-
ment of research subjects. A blinded study design with
randomization either to “Virtual Off” or usual functional
opening pressure settings could determine the true clinical
effect of shunt surgery, as well as determination of cerebral
blood flow and metabolic responses induced by the changed
CSF dynamics from the active shunting. The Certas™ is
designed to prevent the shunt setting from changing in
strong external magnetic fields, such as those associated
with MRI [23], which would prevent inadvertent change of
the shunt setting during the study protocol should the pa-
tient require an “off protocol” MRI for clinical purposes.
Another important feature for the clinician is that, similar
to the Medtronic Strata shunt the setting of the Certas™
shunt can be checked with an indicator tool, thereby
avoiding unnecessary x-rays.
It should be noted that flow in the “Virtual Off” position
has been considered here largely in normal and iNPH
patients. In children and adults with typical “high” pressure
hydrocephalus or with pseudotumour cerebri, flow may be
present even at this setting. While this is likely a positive
safety feature for patients with potentially high pressures
and unlikely to impede its use for treatment of low pressure
problems like subdurals, it should be realized that under
these circumstances shunt removal or ligation differs from
the “Virtual Off” setting.
Conclusions
In conclusion we confirmed that the opening pressures
and outflow resistance of the Certas™ adjustable valve
closely matched the manufacturer’s specifications; and
that pressure measured at the “Virtual Off” setting
exceeded 400 mm H2O for all shunts. The “Virtual Off”
setting may be useful in clinical situations where a reversible
and non-invasively “closed” shunt may be desired. The
“Virtual Off” feature may reduce the need for surgery in the
treatment of subdural hygromas and hematomas, failed
third ventriculostomies and shunt weaning.
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